The PE Ratio as of December 2024 (TTM) for Gritstone bio, Inc. (GRTS) is -0.03

According to Gritstone bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -97.86% compared to the average of -1.38 of the last 4 quarters.

Gritstone bio, Inc. (GRTS) Historical PE Ratio (quarterly & annually)

How has GRTS PE Ratio performed in the past?

The mean historical PE Ratio of Gritstone bio, Inc. over the last ten years is -5.88. The current -0.03 PE Ratio has changed -49.76% with respect to the historical average. Over the past ten years (40 quarters), GRTS's PE Ratio was at its highest in in the March 2021 quarter at 22.61. The PE Ratio was at its lowest in in the December 2021 quarter at -8.40.

Gritstone bio, Inc. (GRTS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gritstone bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gritstone bio, Inc. (GRTS) Average PE Ratio

How has GRTS PE Ratio performed in the past?

The current PE Ratio of Gritstone bio, Inc. (GRTS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Gritstone bio, Inc. (GRTS) PE Ratio vs. Peers

How is GRTS’s PE Ratio compared to its peers?

Gritstone bio, Inc.’s PE Ratio is greater than Aurinia Pharmaceuticals Inc. (-56.96), greater than BridgeBio Pharma, Inc. (-12.25), less than Annovis Bio, Inc. (-0.01), less than ImmunoGen, Inc. (322.18), greater than Generation Bio Co. (-0.49), greater than Kronos Bio, Inc. (-0.67), greater than Erasca, Inc. (-4.56), greater than C4 Therapeutics, Inc. (-2.55), greater than Edgewise Therapeutics, Inc. (-22.36), greater than Kezar Life Sciences, Inc. (-5.00), greater than Fulcrum Therapeutics, Inc. (-15.85), greater than Passage Bio, Inc. (-0.58), greater than InflaRx N.V. (-2.52), greater than Allogene Therapeutics, Inc. (-1.54), greater than G1 Therapeutics, Inc. (-8.39), greater than Heron Therapeutics, Inc. (-8.63), greater than Annexon, Inc. (-6.23), greater than Sangamo Therapeutics, Inc. (-3.86), greater than Affimed N.V. (-0.26), greater than Leap Therapeutics, Inc. (-1.86), greater than Adaptimmune Therapeutics plc (-3.29), greater than Corvus Pharmaceuticals, Inc. (-5.75), greater than Aptose Biosciences Inc. (-0.13),

Build a custom stock screener for Gritstone bio, Inc. (GRTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gritstone bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gritstone bio, Inc. (GRTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gritstone bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.